* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 14 cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 13
cents per share.
* Reported revenue was zero; analysts expected zero.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 14 cents.
* The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Aethlon Medical Inc shares had fallen by 6.0% this
quarter and
gained 22.9% so far this year.
* The company reported a quarterly loss of $3.28 million.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $6.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 10:05 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.13 -0.14 Missed
Mar. 31 2023 -0.13 -0.10 Beat
Dec. 31 2022 -0.08 -0.12 Missed
Sep. 30 2022 -0.21 -0.18 Beat